4 Result(s)

Article

Progression analysis versus traditional methods to quantify slowing of disease progression in Alzheimer’s disease

The clinical meaningfulness of the effects of recently approved disease-modifying treatments (DMT) in Alzheimer’s disease is under debate. Available evidence is limited to short-term effects on clinical rating...

Linus Jönsson, Milana Ivkovic, Alireza Atri, Ron Handels… in Alzheimer's Research & Therapy (2024)

Article

Health-related quality of life in people with predementia Alzheimer’s disease, mild cognitive impairment or dementia measured with preference-based instruments: a systematic literature review

Obtaining reliable estimates of the health-related quality of life (HR-QoL) of people with predementia Alzheimer’s disease [AD] (preclinical or prodromal AD), mild cognitive impairment (MCI) and dementia is es...

Filipa Landeiro, Seher Mughal, Katie Walsh, Elsbeth Nye… in Alzheimer's Research & Therapy (2020)

Article

Erratum to: The societal costs of dementia in Sweden 2012 – relevance and methodological challenges in valuing informal care

Anders Wimo, Linus Jönsson, Laura Fratiglioni… in Alzheimer's Research & Therapy (2017)

Article

The societal costs of dementia in Sweden 2012 – relevance and methodological challenges in valuing informal care

In this study, we sought to estimate the societal cost of illness in dementia in Sweden in 2012 using different costing approaches to highlight methodological issues.

Anders Wimo, Linus Jönsson, Laura Fratiglioni… in Alzheimer's Research & Therapy (2016)